Generics 1



Medical devices



Dalteparin manufacturers

1 products found


1 products found


Solution for injection 2500IU/0.2ml, 5000IU/0.2ml, 7500IU/0.3ml

Dossier type
Dossier status
Ready to file
Country of origin
GMP approvals
Manufacturer #16892

Manufacturer usually replies in 6 days

Dalteparin Manufacturers

Dalteparin Sodium is low molecular weight heparin. It's being used to treat and prevent deep vein thrombosis and pulmonary embolism, as well as to decrease the risk of a cardiac event. Dalteparin is a blood thinner and anticoagulant that is used to avoid ischemic complications associated with unstable angina and non-Q-wave myocardial infarction. It is also used in conjunction with low - dose aspirin to avoid ischemic problems. Antithrombin III activity is enhanced by its activities. Both Factor Xa and thrombin are inhibited as a result of this. Self-injection is the most common method of administration. It has been shown to be more efficient than warfarin in lowering the incidence of recurrent embolic episodes in patients with cancer and acute venous thromboembolism (VTE). Dalteparin Sodium is sold under the brand names Fragmin and many others.

How does Dalteparin work?

Dalteparin Sodium is a kind of heparin with a low molecular weight. It possesses antithrombotic effects, which work through increasing antithrombin's inhibition of Factor Xa and thrombin. Dalteparin Sodium potentiates the inhibition of coagulation Factor Xa preferentially. However, it can only have a minor impact on the activated clotting time.

The Wholesale Price of Dalteparin

An online search for the wholesale price for sale of Dalteparin for distributors will reveal a wide range of costs. It will vary from store to store depending on your visit and the country of the wholesale market. In the USA, the consumers have to pay USD 275 for a supply of 2 milliliters, of the subcutaneous solution with 2500 IU equal to 0.2 mL. In India, the 7500 IU injection costs around USD 6.16, and the the10000 IU costs around USD 7.17.

Navigating our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Dalteparin distributors offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and this substance Dalteparin suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Dalteparin. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Dalteparin is already registered in. Manufacturers also have special, and delivery terms.

Establishing Commercial Ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical product deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers and Dalteparin suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Dalteparin Manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.